I obtained a Degree in Biochemistry (2019) and a Master's in Biochemistry (2022), both from the Faculty of Sciences of the University of Beira Interior. In this path, I elaborated a theoretical project "Modulation of microglial reactivity in the context of Parkinson's disease, using anti-inflammatories intended to modulate peripheral inflammation" and, in the last year of the Master's, the dissertation entitled "Modulation of neuroinflammation by 5'-ASA". This study was based on the evaluation of the modulating effect of an anti-inflammatory (5'-ASA) used as a mediator in intestinal inflammatory pathologies, in neuroinflammation processes, under Dr. Ana Clara Braz Cristóvão (Ph.D.) guidance and co-supervision by Mariana Bernardo Fiadeiro (Ph.D. student). This study resulted in a scientific review publication. Throughout this academic training, laboratory skills were acquired and improved, such as the elaboration and behavioral evaluation in experiments with rodents, working with cell cultures, microglia, astrocytes, and dopaminergic neurons, techniques such as ELISA, protein extraction, and immunostaining, and handling samples biological substances from different sources and chemical products following safety rules and good laboratory practices. During my academic career, I was a member of the councils of the University of Beira Interior, the Pedagogical Council of the Faculty of Sciences, and the General Council of this university, as well as a member and president of organizing entities for scientific events. Since 2022, I have co-supervised a Master's student in Biotechnology in his dissertation, two Bachelor's students in Biochemistry in their final theoretical project, and two Bachelor's students in Biomedical Sciences in their laboratory projects. From June 2022 to July 2023, I was a research fellow in the project "PDSolve - New therapeutic approach to slow down the progression of Parkinson's disease" (CENTRO-01-0247-FEDER-113213), which addresses the role of NADPH oxidase 1 (NOX1) in Parkinson's disease, with therapeutic development based on ionic liquids (IL) for this pathology. Currently, I am a PhD student in Biomedicine.